Company Filing History:
Years Active: 2008
Title: Hae-Ryong Park: Innovator in Tetronic Acid Derivatives
Introduction
Hae-Ryong Park is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of molecular biology through his innovative research and development of novel compounds. His work focuses on substances that can regulate the expression of molecular chaperones, which are crucial for cellular function.
Latest Patents
Hae-Ryong Park holds a patent for a tetronic acid derivative, specifically the versipelostatin compound, also known as JL68. This compound has demonstrated the ability to suppress the expression of GRP78, a molecular chaperone. The discovery was made by isolating the compound from the metabolite of strain 4083-SVS6, which was cultured to obtain the compound from the culture supernatant.
Career Highlights
Park is associated with Toudai Tlo, Ltd., where he continues to advance his research. His work has garnered attention for its potential applications in therapeutic settings, particularly in diseases where GRP78 plays a significant role.
Collaborations
Hae-Ryong Park has collaborated with notable colleagues, including Kazuo Shinya and Takashi Tsuruo. These partnerships have enhanced the scope and impact of his research, contributing to advancements in the field.
Conclusion
Hae-Ryong Park's innovative work in developing tetronic acid derivatives highlights his commitment to scientific advancement. His contributions are paving the way for future research and potential therapeutic applications.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.